Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000902664-18-002202
Filing Date
2018-05-11
Accepted
2018-05-11 13:35:52
Documents
1

Document Format Files

Seq Description Document Type Size
1 AZURRX BIOPHARMA, INC. p18-1078sc13g.htm SC 13G 73247
  Complete submission text file 0000902664-18-002202.txt   75030
Mailing Address 40 WEST 57TH ST. 32ND FLOOR NEW YORK NY 10019
Business Address 40 WEST 57TH ST. 32ND FLOOR NEW YORK NY 10019 2122874900
HIGHBRIDGE CAPITAL MANAGEMENT LLC (Filed by) CIK: 0000919185 (see all company filings)

EIN.: 134131516 | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226
Business Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226 646-699-7855
AzurRx BioPharma, Inc. (Subject) CIK: 0001604191 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
Type: SC 13G | Act: 34 | File No.: 005-89966 | Film No.: 18826172
SIC: 2834 Pharmaceutical Preparations